10 insiders reported 49 Form 4 transactions for Xenon Pharmaceuticals Inc. (XENE) over the past 18 months (most recent 2026-08-13). Recent activity: GANNON STEVEN (Director) Sell 10,000 shares, PATOU GARY (Director) Sell 1,322 shares, Cannon Gillian (Director) Sell 1,190 shares, PATOU GARY (Director) Buy 2,645 shares, Machado Patrick (Director) Buy 2,645 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-13 | GANNON STEVEN | Director | Sell | 10,000 | $640,550 |
| 2026-06-08 | PATOU GARY | Director | Sell | 1,322 | $70,251 |
| 2026-06-08 | Cannon Gillian | Director | Sell | 1,190 | $63,237 |
| 2026-06-03 | PATOU GARY | Director | Buy | 2,645 | $0 |
| 2026-06-03 | Machado Patrick | Director | Buy | 2,645 | $0 |
| 2026-06-03 | Svoronos Dawn | Director | Buy | 2,645 | $0 |
| 2026-06-03 | GANNON STEVEN | Director | Buy | 2,645 | $0 |
| 2026-06-03 | Gover Justin D. | Director | Buy | 2,645 | $0 |
| 2026-06-03 | GAROFALO ELIZABETH A. | Director | Buy | 2,645 | $0 |
| 2026-06-03 | Cannon Gillian | Director | Buy | 2,645 | $0 |
| 2026-06-03 | Svoronos Dawn | Director | Sell | 1,416 | $75,629 |
| 2026-06-03 | GANNON STEVEN | Director | Sell | 1,416 | $75,629 |
| 2026-05-13 | GANNON STEVEN | Director | Buy | 3,500 | $25,830 |
| 2026-03-13 | MORTIMER IAN | PRESIDENT & CEO | Buy | 12,500 | $0 |
| 2026-03-13 | MORTIMER IAN | PRESIDENT & CEO | Sell | 7,308 | $403,621 |
| 2026-03-13 | DiFabio Andrea | Chief Legal Officer | Buy | 3,750 | $0 |
| 2026-03-13 | DiFabio Andrea | Chief Legal Officer | Sell | 1,342 | $74,119 |
| 2026-03-13 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | Buy | 3,750 | $0 |
| 2026-03-13 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | Sell | 1,410 | $77,874 |
| 2026-03-11 | DiFabio Andrea | Chief Legal Officer | Buy | 7,500 | $0 |
| 2026-03-11 | DiFabio Andrea | Chief Legal Officer | Sell | 2,607 | $156,707 |
| 2026-03-11 | MORTIMER IAN | PRESIDENT & CEO | Buy | 75,000 | $630,000 |
| 2026-03-11 | MORTIMER IAN | PRESIDENT & CEO | Sell | 21,791 | $1.3M |
| 2026-03-11 | MORTIMER IAN | PRESIDENT & CEO | Sell | 31,694 | $1.9M |
| 2026-03-11 | MORTIMER IAN | PRESIDENT & CEO | Sell | 21,515 | $1.3M |
Source: SEC Form 4 filings · as of 2026-08-13